<\/p>\n
Dytor Injection is a 2 ml ampoule containing torasemide 10 mg \u2014 a potent loop diuretic used intravenously to rapidly remove excess fluid in congestive heart failure, pulmonary oedema and severe oedema from liver or kidney disease. Manufactured by Cipla, it is administered by a healthcare professional and begins diuresis within 10 minutes of IV injection.<\/p>\n<\/div>\n
\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n Dytor Injection is a sterile solution of torasemide 10 mg per 2 ml ampoule<\/strong>, intended for intravenous or intramuscular administration. Torasemide is a potent loop diuretic of the pyridine-sulfonylurea class, closely related to furosemide but with a longer duration of action and more predictable oral bioavailability. Manufactured by Cipla Ltd in India, Dytor is a widely prescribed injectable diuretic in cardiac care units and emergency departments.<\/p>\n The injection provides rapid diuresis \u2014 onset within 10 minutes of IV administration \u2014 which makes it the treatment of choice for acute pulmonary oedema and decompensated heart failure where rapid fluid removal is clinically critical. Compared with furosemide, torasemide has better oral-to-IV conversion consistency (approximately 1:1), so patients can be transitioned to oral therapy without dose adjustment.<\/p>\n Torasemide acts on the thick ascending limb of the loop of Henle<\/strong> in the kidney, where it inhibits the sodium-potassium-chloride cotransporter (Na\u207a\/K\u207a\/2Cl\u207b symporter, NKCC2). By blocking reabsorption of sodium and chloride from the tubular fluid, it causes large volumes of water to remain in the urine rather than being reabsorbed into the bloodstream. The result is rapid, potent diuresis that reduces circulating blood volume, pulmonary capillary pressure and tissue oedema.<\/p>\n Torasemide differs from furosemide in two important ways: it has a longer half-life (3\u20134 hours versus 1\u20132 hours for furosemide), producing a smoother, more sustained diuretic effect; and it has additional weak anti-aldosterone activity, reducing the degree of potassium loss for equivalent diuretic output.<\/p>\n Dytor Injection dosage is individualised based on clinical response:<\/p>\nWaarom bestellen bij MedsBase<\/h3>\n
What Is Dytor Injection?<\/h2>\n
Uses of Dytor Injection<\/h2>\n
\n
How Dytor Works<\/h2>\n
How Dytor Works<\/h2>\n
Dosering en toediening<\/h2>\n